Analysed ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) News Sources
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
20-04-2026
yahoo.com
Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money
20-04-2026
yahoo.com
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
30-04-2026
yahoo.com
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
13-05-2026
yahoo.com
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20-05-2026
yahoo.com
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
27-05-2026
yahoo.com
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
04-06-2026
yahoo.com
What is the current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is $3.55.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is $-0.03.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is -0.838%.
What is the most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is .
SEC-8K** Filing Available For ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.